GNL3L and breast carcinoma: Results from the HPA database showed that GNL3L protein was expressed in stomach cancer, testis cancer, melanoma, lung cancer, skin cancer, liver cancer, breast cancer, ovarian cancer, endometrial cancer, 10-lymphoma-1, 11-renal cancer-1, and 12-pancreatic cancer-1 significantly higher than in normal tissue (Figure 2).